DR REDDY'S LABORATORIES (UK) LIMITED

This page summarises award records that name this supplier and the public buyers listed alongside it. Published names are joined when identifiers or close name matches support the link.

Award history

Published records by year

Each row counts award records linked to this supplier. A single procurement can produce more than one award.

Annual award records and published value assigned to this supplier
Year	Awards	Value counted	Values not counted
2026	3	Value not published	3
2025	7	Value not published	7
2024	6	Value not published	6
2023	2	Value not published	2

Buyer relationships

Buyer relationships by value counted

Ranked by published value assigned to this supplier, then by award count.

SupplierDR REDDY'S LABORATORIES (UK) LIMITED

Source records

Published awards

Page 1 of 2 · 40 records.

NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026
Buyer: NHS England
End date in notice
31 Aug 2028Date from the linked contract
Value shown in notice
£813,863,584Value from the linked contract
Official source
Open the official Find a Tender notice for NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026
About this figure
- This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.
- This figure comes from the linked contract record. Overall totals continue to use the separately published award value.
View record references
Source
Find a Tender
Award or lot reference
ocds-h6vhtk-051a9d / 3
Lot 2 - CM/PHG/23/5699/02 CM/PHG/23/5699/02 Hospital only products
Buyer: NHS England

DR REDDY'S LABORATORIES (UK) LIMITED

Published records by year

Buyer relationships by value counted

Published awards

NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026

Lot 2 - CM/PHG/23/5699/02 CM/PHG/23/5699/02 Hospital only products

Transitional Drugs 6

NHS National Framework for Generics Housekeeping - Lot 2 Hospital Only products

NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin

NHS National Framework for Transition Products (Nintedanib and Dalbavancin)

NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025

NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National

Lot 1 - CM/PHG/23/5699/01 Oral (plus non-parenteral) products

NHS National Framework - Generics Housekeeping/Supply Chain Resilience Products

NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)

NHS National Framework for Transition products (Axitinib and Eltrombopag)

NHS National Framework for Transition products (Nilotinib and Ticagrelor)

NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024

NHS Branded Medicines Tranche Framework for London and South of England

NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

CM/TNS/24/5713 - NHS Framework for Transition products - 1 February 2025

NHS National Framework for Transition products commencing 1 October 2024

NHS National Framework for Transition products commencing 1 May 2024

NHS National Generic Pharmaceuticals Wave 14b